Deshan Li
Impact in
-
- Lipid metabolism and disorders
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
- Epidemiology 15
- Virology and Viral Diseases 8
-
- Monoclonal and Polyclonal Antibodies Research 11
- Co-authors
- Christopher C. Fraser (1 shared paper)Amy Ford (1 shared paper)Anja Köster (1 shared paper)Marian Mosior (1 shared paper)S. Richard Jaskunas (1 shared paper)Yubin Qiu (1 shared paper)Patricia A. Gonzalez‐DeWhitt (1 shared paper)Patrick I. Eacho (1 shared paper)
- Journals
- International Immunopharmacology (4 papers)Current Pharmaceutical Biotechnology (3 papers)Sustainability (3 papers)Biomedicine & Pharmacotherapy (3 papers)Materials and Corrosion (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Deshan Li
46 papers receiving 724 citations
Peers
Comparison fields: 5 of 94
- Cardiology and Cardiovascular Medicine 319
- Endocrinology, Diabetes and Metabolism 136
- Cancer Research 102
- Hepatology 34
- Immunology 91
Countries citing papers authored by Deshan Li
This map shows the geographic impact of Deshan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deshan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deshan Li more than expected).
Fields of papers citing papers by Deshan Li
This network shows the impact of papers produced by Deshan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deshan Li. The network helps show where Deshan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Deshan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 365 | |
| 2 | 2012 | 30 | |
| 3 | 2016 | 26 | |
| 4 | 2022 | 23 | |
| 5 | 2015 | 23 | |
| 6 | 2013 | 19 | |
| 7 | 2018 | 17 | |
| 8 | 2022 | 15 | |
| 9 | 2017 | 15 | |
| 10 | 2018 | 14 | |
| 11 | 1994 | 13 | |
| 12 | 2012 | 13 | |
| 13 | 2014 | 13 | |
| 14 | 2018 | 12 | |
| 15 | 2020 | 11 | |
| 16 | 2019 | 10 | |
| 17 | 2016 | 9 | |
| 18 | 2018 | 9 | |
| 19 | 2013 | 8 | |
| 20 | 2016 | 8 |
About Deshan Li
Deshan Li is a scholar working on Epidemiology, Radiology, Nuclear Medicine and Imaging, Immunology, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 48 papers that have together received 741 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (11 papers), Virology and Viral Diseases (8 papers), Animal Virus Infections Studies (5 papers), Virus-based gene therapy research (5 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Viral Infections and Immunology Research (4 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Environmental Impact and Sustainability (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (319 citations), Endocrinology, Diabetes and Metabolism (136 citations), Cancer Research (102 citations), Hepatology (34 citations) and Immunology (91 citations). Deshan Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Christopher C. Fraser, Amy Ford, Anja Köster, Marian Mosior, S. Richard Jaskunas, Yubin Qiu, Patricia A. Gonzalez‐DeWhitt, Patrick I. Eacho, Josef G. Heuer and Ye Chao. Their work appears in journals such as International Immunopharmacology, Current Pharmaceutical Biotechnology, Sustainability, Biomedicine & Pharmacotherapy and Materials and Corrosion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.